Health & Fitness:Medicine
Cerebral amyloid angiopathy (CAA) has been gaining attention over the past few years, thanks to increased research in the field. Professor David Werring (UCL Institute of Neurology, Queens Square, London) discusses the recent advances in biomarkers analysis, as well as providing an overview of the clinical spectrum of CAA. Read the full paper here: http://jnnp.bmj.com/content/early/2017/08/26/jnnp-2016-314697
More Episodes
Cyclophosphamide for myasthenia gravis: a comeback?
2025-04-17
728
2025-04-17
728
Management methods for acute ischaemic stroke
2025-02-13
1.3k
2025-02-13
1.3k
Nutritional peripheral neuropathies, with Dr. Alexander Rossor
2024-04-17
1.9k
2024-04-17
1.9k
Distinguishing primary from functional tics
2024-02-19
1.9k
2024-02-19
1.9k
Nitrous Oxide Abuse
2023-09-22
2.2k
2023-09-22
2.2k
Brain Fog Demystified
2023-08-08
2.6k
2023-08-08
2.6k
A roadmap to ALS prevention: strategies and priorities
2023-06-15
2.2k
2023-06-15
2.2k
MOGAD: Definition, diagnosis and treatment
2023-05-15
1.7k
2023-05-15
1.7k
Cerebral Microbleeds: from depiction to interpretation
2021-07-05
366
2021-07-05
366
Motor functional neurological disease, a decade of progress
2021-06-25
342
2021-06-25
342
Drug repurposing for progressive multiple sclerosis
2021-03-02
230
2021-03-02
230
Get this podcast on your
phone, FREE
